This study evaluated the impact of the highly selective and potent H3R antagonist E159 on autism-like behaviors in BTBR mice and examined the effects of sub-chronic treatment with E159 on pro-inflammatory cytokines in cerebellum and hippocampus of treated mice. The gene discussed is HRH3; the disease is autism.